A number of studies have investigated possible roles for polymorphisms in several 1C metabolism genes in cancer, including those in TS, which may affect CRC susceptibility, disease progression, and TS-targeted chemotherapy [14,15,16,17,18]. This evidence concerns the gene TYMS and cancer.